Oncogene – celebrates 20 years of shaping the scientific community and publishing the latest developments in cancer research. Oncogene is published weekly and covers the structure and function of oncogenes.
Free online issue
Volume 28, No 26
02 July 2009
ISSN: 0950-9232
EISSN: 1476-5594
2008 impact factor 7.216*
13/141 Oncology
14/138 Genetics & Heredity
26/157 Cell Biology
29/276 Biochemistry & Molecular Biology
Editor-in-Chief:
Douglas R. Green
*2008 Journal Citation Reports (Thomson Reuters, 2009)
FEATURED ARTICLES
ORIGINAL ARTICLE
Choline kinase-
in human bladder cancer
FREE ORIGINAL ARTICLE
Pin1 regulates Akt stabilityORIGINAL ARTICLE
Myc inhibition of C/EBP
REVIEW
PAK signaling in oncogenesis FREEORIGINAL ARTICLE
Functional interaction between WWOX and Wnt pathway FREEREVIEW
Metabolic flux analysis of Myc-dependent cell-cycle entryOncogene News
Healing telomeres. Exploring Tankyrase 1's effect on genomic stability could help develop novel breast cancer therapies. Read how these cell mutations affect BRCA associated cancers through spindle dysfunction. FREE
Web Focus: Stem Cell Therapy. The vast medical potential and recent advances in embryonic and adult stem cell biology create a further need to better communicate novel findings among the scientific community. Read this multi-journal web focus compiling free articles dedicated to the advancement of stem cell research.
Oncogene Reviews. Mechanizing apoptosis is one of many possible future applications involving PTEN. Read this and other issues of Oncogene Reviews highlighting a broad spectrum of topics including microRNA's, antibody therapies for cancer and FOXO.
Submit your paper to Nature Precedings while your manuscript is under consideration. This archive provides a rapid way to disseminate emerging results and new theories, solicit opinions, and record the provenance of ideas. Register to submit documents now.
Other NPG news
Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
